CONTACT
Home
About Us
ImmunoCellular History
Management
Board of Directors
Contact Us
Technology
Cancer Immunotherapy
Stem-to-T-Cell Platform
Dendritic Cell-Based Immunotherapeutics
Dendritic Cell-Based Manufacturing
Publications
Resources
Pipeline
Stem-to-T-Cell
ICT-107
ICT-121
ICT-140
Investors
Press Releases
Events & Presentations
Stock information
Historic stock lookup
Investment Calculator
Dividend Policy
Analyst Coverage
Ownership Profile
Financial Information
Key ratios
SEC Filings
Corporate Governance
Board of Directors
Committee Composition
Shareholder Briefcase
RSS Feeds
Mobile Investor
Snapshot
Downloads
Business Development
MENU
Home
About Us
ImmunoCellular History
Management
Board of Directors
Contact Us
Technology
Cancer Immunotherapy
Stem-to-T-Cell Platform
Dendritic Cell-Based Immunotherapeutics
Dendritic Cell-Based Manufacturing
Publications
Resources
Pipeline
Stem-to-T-Cell
ICT-107
ICT-121
ICT-140
Investors
Press Releases
Events & Presentations
Stock information
Historic stock lookup
Investment Calculator
Dividend Policy
Analyst Coverage
Ownership Profile
Financial Information
Key ratios
SEC Filings
Corporate Governance
Board of Directors
Committee Composition
Shareholder Briefcase
RSS Feeds
Mobile Investor
Snapshot
Downloads
Business Development
EVENTS & presentations
March 13, 2018 - ImmunoCellular Therapeutics Fourth Quarter 2017 Conference Call & Webcast
Listen to webcast
Additional Information
PRESS RELEASES
Monday, May 14, 2018
ImmunoCellular Therapeutics Announces First Quarter 2018 Financial Results
read more ...
Thursday, April 12, 2018
ImmunoCellular Therapeutics Announces Achievement of Next Key Milestone in Stem-to-T-Cell Research
read more ...
Monday, March 26, 2018
ImmunoCellular Therapeutics Receives Audit Opinion with Going Concern Explanation
read more ...
Home
About Us
Technology
Pipeline
Investors
Business Development
Terms of Use
|
Privacy Policy
|
Contact
Copyright 2018 by Immunocellular Therapeutics, Ltd.
All Rights Reserved
Login